HMOX1 and metabolic dysfunction-associated steatohepatitis: Subsequent functional in vivo studies indicated that pharmacological suppression of HMOX1 can alleviate liver injury, inflammation, and fibrosis in long-term HFHC diet-induced NASH mice.